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Novel Association in Chromosome 4q27 Region with Rheumatoid
Arthritis and Confirmation of Type 1 Diabetes Point to a General
Risk Locus for Autoimmune Diseases
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Gerrit van der Steege, Timothy R. D. J. Radstake, Pilar Barrera, Bart O. Roep,
Bobby P. C. Koeleman, and Cisca Wijmenga
Recently, association of celiac disease with common single-nucleotide polymorphism (SNP) variants in an extensive
linkage-disequilibrium block of 480 kb containing the KIAA1109, Tenr, IL2, and IL21 genes has been demonstrated in
three independent populations (rs6822844 ). The KIAA1109/Tenr/IL2/IL21 block corresponds to the514P p 1.3# 10combined
Idd3 locus in the nonobese diabetic mouse model of type 1 diabetes (T1D). This block was recently found to be associated
with T1D in a genomewide association study, although this finding lacks unequivocal confirmation. We therefore aimed
to investigate whether the KIAA1109/Tenr/IL2/IL21 region is involved in susceptibility to multiple autoimmune diseases.
We tested SNP rs6822844 for association with disease in 350 T1D-affected and 1,047 rheumatoid arthritis (RA)–affected
Dutch patients and in 929 controls. We replicated the association with T1D ( ; OR 0.64 [95% CI 0.50–0.83]),Pp .0006
and revealed a similar novel association with RA ( ; OR 0.72 [95% CI 0.61–0.86]). Our results replicate andPp .0002
extend the association found in the KIAA1109/Tenr/IL2/IL21 gene region with autoimmune diseases, implying that this
locus is a general risk factor for multiple autoimmune diseases.
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Type 1 diabetes (T1D [MIM 222100]), rheumatoid arthritis
(RA [MIM 180300]), and celiac disease (CD [MIM 212750])
are common autoimmune diseases (AIDs), each affecting
∼1% of the general population. The manifestation and
progression of AIDs depend on a combination of multiple
genetic and environmental factors, yet the co-occurrence
of these three different AIDs in families, or even within
single patients, has been reported frequently.1–3 For in-
stance, 6.2% of patients with T1D also have CD,4 and 2.8%
of first-degree relatives of RA-affected probands have T1D.1
This overlap in etiology is most likely due to a shared
genetic predisposition to autoimmunity. The well-known
and major genetic risk factor for all three diseases are the
human leukocyte antigen class II genes. Other risk factors
in common that have been confirmed in various AIDs are
the PTPN22 (MIM 600716) (in T1D and RA) and CTLA4
(MIM 123890) (in T1D and CD) genes, where the differ-
ences in overlap may point to differences in disease
pathways.5
The region encompassing KIAA1109/Tenr/IL2/IL21 is
contained in a large block (480 kb) of linkage disequilib-
rium (LD) recently reported to be a strong genetic factor
involved in CD.6 This block is located on chromosome
4q27 and includes the IL2 (MIM 147680) and IL21 (MIM
605384) genes, which are both plausible functional can-
didate loci for AIDs. IL2 is a susceptibility gene in the
nonobese diabetic (NOD) mouse model of T1D,7 and as-
sociation of the IL2 receptor (IL2RA and CD25 [MIM
147730]) to T1D has been demonstrated in extended co-
horts, highlighting the importance of the IL2 pathway
in the predisposition to AIDs.8,9 Both IL2 and IL21 belong
to the type 1 cytokine family, share a large degree of
homology, and possess pleotropic functions in immune
cells.10,11
Hence, the association of the KIAA1109/Tenr/IL2/IL21
gene region with T1D in mouse and with CD in human
may reflect a general role for this locus in the etiology of
autoimmunity. Given the comorbidity among CD, T1D,
and RA, we sought to confirm this hypothesis by testing
the most associated CD variant from the U.K. genomewide
association (GWA) screen (rs6822844) in a Dutch T1D co-
hort and a Dutch RA cohort.
The patients with T1D were retrieved from the Kolibri
T1D cohort, which includes 350 patients with juvenile-
onset T1D (median age 8.7 years [range 1–17 years]). The
cohort was collected consecutively after diagnosis by pe-
diatricians in the southwestern part of the Netherlands
between 1995 and 1999. The diagnosis was made accord-
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Table 1. Frequency of SNP rs6822844 in Controls ( ), Patients with T1D ( ), and Patientsnp 929 np 350
with RA ( )np 1,047
rs6822844 Control Counts (%)
Patients with T1D Patients with RA
Counts (%) OR (95% CI) P Counts (%) OR (95% CI) P
Allele G 1,506 (81.5) 585 (87.3) 1 (ref) … 1,739 (85.9) 1 (ref) …
Allele T 342 (18.5) 85 (12.7) .64 (.50–.83) .0006 285 (14.1) .72 (.61–.86) .0002
GG 613 (66.3) 258 (77.0) 1 (ref) … 748 (73.9) 1 (ref) …
GT 280 (30.3) 69 (20.6) .59 (.44–.80) .0014 243 (24.0) .71 (.58–.87) .0009
TT 31 (3.4) 8 (2.4) .67 (.31–1.44) … 21 (2.1) .56 (.32–.99) …
NOTE.—ref p Reference. The number of dropouts was 5 in controls, 14 in patients with T1D, and 35 in patients with RA.
Reported P values were obtained with 1-df test for allelic effect and 2-df test for genotyping effect.
Table 2. Frequency of SNP rs4505848 in Controls ( ), Patients with T1D ( ), and Patientsnp 929 np 350
with RA ( )np 1,047
rs4505848 Control Counts (%)
Patients with T1D Patients with RA
Counts (%) OR (95% CI) P Counts (%) OR (95% CI) P
Allele A 1,180 (65.1) 417 (63.8) 1 (ref) … 1,270 (62.9) 1 (ref) …
Allele G 632 (34.9) 237 (36.2) 1.06 (.88–1.28) .53 750 (37.1) 1.10 (.97–1.26) .15
AA 380 (41.9) 144 (44.0) 1 (ref) … 396 (39.2) 1 (ref) …
AG 420 (46.4) 129 (39.4) .81 (.62–1.07) .03 478 (47.3) 1.09 (.90–1.32) .34
GG 106 (11.7) 54 (16.5) 1.35 (.93–1.97) … 136 (13.5) 1.23 (.92–1.64) …
NOTE.—ref p Reference. The number of dropouts was 23 in controls, 23 in patients with T1D, and 37 in patients with RA.
Reported P values were obtained with 1-df test for allelic effect and 2-df test for genotyping effect.
ing to International Society of Pediatric and Adolescent
Diabetes and World Health Organization criteria. The RA
group comprised two independent cohorts from Gron-
ingen ( ) and Nijmegen ( ). The character-np 408 np 639
istics of patients with RA in the Nijmegen cohort have
been described elsewhere.12 All the patients were given
diagnoses in accordance with American College of Rheu-
matology (ACR) criteria for RA,13 had a disease duration
of 11 year, and had no history of using disease-modifying
antirheumatic drugs or biological agents before presen-
tation. The patients with RA in the Groningen cohort were
recruited from the outpatient clinic of the Department
of Rheumatology, University Medical Center Groningen
(UMCG). All patients were given diagnoses in accordance
with ACR criteria13 and had rheumatoid factor (RF)–pos-
itive and/or RF-erosive RA. Patients with T1D and RA were
first compared with a panel of 929 unrelated Dutch con-
trols who were genotyped and presented in the replication
GWA study for CD.6 All the patients and controls gave
their informed consent, and the medical ethics commit-
tees of the University Medical Center Utrecht, the UMCG,
and the Radboud University Nijmegen Medical Center ap-
proved the respective original studies.
Genotyping was performed using TaqMan technology.
SNP genotyping assays for PCR were supplied by Applied
Biosystems, as described elsewhere.6 The DNA samples
were processed in 384-well plates. Each plate contained 8
negative controls and 16 genotyping controls (4 duplicates
of four different CEPH samples). In the control group, the
frequencies of all the SNPs were in Hardy-Weinberg equi-
librium. Hardy-Weinberg equilibrium was tested by com-
paring the expected and observed genotypes in a 2#3
x2 table. Odds ratios (ORs) were calculated, and the CIs
were approximated using Woolf’s method with Haldane’s
correction.14
The rs6822844 GrT SNP was tested in 350 patients with
early-onset T1D and in 1,047 patients with RA. We saw a
decrease in frequency of the rs6822844*T allele in both
T1D (12.7%) and RA (14.1%) groups compared with con-
trols (18.5%); this is similar to our earlier result for CD in
the Dutch population (12.4%).6 The association was sig-
nificant in both T1D ( ; OR 0.64 [95% CI 0.50–Pp .0006
0.83]) and RA ( ; OR 0.72 [95% CI 0.61–0.86])Pp .0002
(table 1).
While we were performing this study, the results of a
GWA study of T1D became available.15 One of the reported
loci was on 4q27 and contained the KIAA1109/Tenr/IL2/
IL21 gene region. A follow-up replication study indicated
moderate association of SNPs in the KIAA1109/Tenr/IL2/
IL21 gene region with T1D.8 We compared the SNPs from
the T1D GWA study with the haplotype-tagging (ht) SNPs
that we used for replicating the CD GWA results and ob-
served that the most T1D-associated SNP (rs3136534
ArC) was in complete LD with one of the SNPs included
in the CD screen (rs4505848 ArG) ( ; LOD 32.262r p 1
[HapMap data]), where the rs3136534*A allele corre-
sponds to rs4505848*A and rs3136534*C corresponds
to rs4505848*G. The haplotype structure and LD in the
region were investigated using HapMap data16 with the
Haploview application.17
We also genotyped the rs4505848 ArG SNP in our co-
horts of patients with T1D and RA and found a slight
increase of the rs4505848*G allele in patients with T1D
(36.2%) and RA (37.1%) compared with controls (34.9%).
Although the observed difference in allele frequency was
not significant in either T1D ( ; OR 1.06 [95% CIPp .53
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Table 3. Haplotype Analysis of SNPs rs4505848, rs11732095, rs6822844, rs4492018, and rs1398553
Haplotype
Control
Counts
(%)
Patients with RA Patients with T1D Patients with CD
Counts
(%) OR (95% CI) P
Counts
(%) OR (95% CI) P
Counts
(%) OR (95% CI) P
GAGGA 536 (29.1) 636 (31.2) 1 Ref 192 (29.0) 1 Ref 312 (31.1) 1 Ref
AAGAG 409 (22.2) 433 (21.2) .89 (.75–1.07) .21 161 (24.3) .91 (.71–1.16) .45 216 (21.5) .91 (.73–1.13) .38
AATGG 343 (18.6) 283 (13.9) .70 (.57–.85) .00025 87 (13.2) .71 (.53–.95) .018 124 (12.4) .62 (.49–.80) .00016
AAGGG 213 (11.6) 293 (14.3) 1.16 (.94–1.43) .17 81 (12.2) 1.07 (.79–1.44) .70 150 (15.0) 1.21 (.94–1.56) .14
AGGGG 154 (8.3) 176 (8.6) 1.04 (.81–1.33) .76 49 (7.5) .90 (.63–1.29) .52 91 (9.0) 1.02 (.76–1.37) .92
GAGGG 101 (5.4) 108 (5.3) .90 (.67–1.21) .49 41 (6.2) 1.15 (.77–1.70) .54 61 (6.1) 1.04 (.74–1.47) .84
AAGGA 67 (3.6) 71 (3.5) .89 (.63–1.27) .53 43 (6.5) 1.72 (1.13–2.62) .01 34 (3.4) .88 (.57–1.36) .54
NOTE.—Combined frequency of haplotypes presented is 198%. Ref p reference.
Table 4. Frequency of SNP rs6822844 in Patients with RF-Positive ( ) and RF-Negativenp 664
( ) RA Compared with Controlsnp 112
rs6822844
Control Counts
(%)
RF Positive RF Negative
Counts (%) OR (95% CI) P Counts (%) OR (95% CI) P
Allele G 1,506 (81.5) 1,143 (86.1) 1 (ref) … 187 (83.5) 1 (ref) …
Allele T 342 (18.5) 185 (13.9) .71 (.59–.87) .0006 37 (16.5) .89 (.61–1.29) .47
GG 613 (66.3) 491 (73.9) 1 (ref) … 79 (70.5) 1 (ref) …
GT 280 (30.3) 161 (24.2) .72 (.57–.90) .0028 29 (25.9) .82 (.52–1.28) .63
TT 31 (3.4) 12 (1.8) .51 (.26–.99) … 4 (3.6) 1.20 (.43–3.31) …
NOTE.—ref p Reference.
0.88–1.28]) or RA ( ; OR 1.10 [95% CI 0.97–1.26]),Pp .15
it did show a trend similar to that reported for the U.K.
T1D-affected population (OR 1.11)8,15 (table 2).
We further investigated the haplotypes of the KIAA1109/
Tenr/IL2/IL21 gene region by typing three additional ht
SNPs: rs11732095, rs4492018, and rs1398553. The com-
bined five SNPs tag seven haplotypes of the block in which
rs6822844 is located. These haplotypes have a combined
frequency of 198%. Interestingly, rs6822844 is a perfect
proxy for the AATGG haplotype, which is the most as-
sociated haplotype in all three diseases with haplotype
frequencies of ∼13% in cases versus 18.6% in controls
(table 3).
Interestingly, a reported RA association with PTPN22-
1858T, another general autoimmune risk factor, was pref-
erentially observed in the subgroup of patients with RF-
positive RA18; similarly, linkage to the PTPN22 region is
also limited to families with RF-positive RA.19 We inves-
tigated whether the association in our RA group was de-
pendent on the presence of RF. Information about RF was
available for 776 individuals genotyped for rs6822844, of
whom 664 had RF-positive RA. We did not observe a sig-
nificant difference in association between the RF-positive
and RF-negative groups, although the protective effect in
the RF-positive group was moderately stronger than in the
RF-negative group (OR 0.71 [95% CI 0.59–0.87] and OR
0.89 [95% CI 0.61–1.29], respectively) (table 4).
To estimate overall association of the studied SNPs with
AIDs in the Dutch population, we then pooled all the
Dutch patients with T1D, RA, and CD into one group
(Dutch AIDs), which was compared with controls. This
group was then included in a meta-analysis with recently
published data from a U.K. and Irish CD genome-scan
study presented elsewhere,6 with use of a random-effect
model. There was no significant heterogeneity among the
studies. In total, 6,236 patient chromosomes and 5,812
control chromosomes were included in the meta-analysis.
Overall, a meta-analysis of our findings showed a consis-
tently lower frequency of the rs6822844*T allele (random
model test for an overall effect, ). It yielded aP ! .00001
1.5-fold decrease (95% CI 1.36–1.69) in risk of AIDs in
carriers (OR 0.67 [95% CI 0.59–0.74]) (fig. 1).
In this study, we have identified the 4q27 KIAA1109/
Tenr/IL2/IL21 gene region as a general autoimmune lo-
cus, since we have shown genetic association with three
AIDs—namely, CD, T1D, and RA. These results were cor-
roborated by the recent report of a GWA study of T1D.15
The KIAA1109/Tenr/IL2/IL21 block is characterized by ex-
tremely strong LD that shows a very similar pattern in the
different populations studied (HapMap CEU, Dutch, U.K.,
and Irish).6 Four SNPs, all in strong LD with each other,
tag the same haplotype and show strong association with
CD in multiple populations. Other common SNPs located
in the KIAA1109/Tenr/IL2/IL21 gene region have shown
strong association with T1D in a recent GWA study.15 How-
ever, a large replication study of T1D in a U.K. population
reported only moderate association with rs3136534, the
most associated SNP in the study.8 rs4505848 is a perfect
proxy for rs3136534 ( ), and it was included in both2r p 1
the CD GWA study and the replication analysis. In the
three CD-affected populations tested, this proxy SNP was
related to only a moderate increase in the frequency of
the G allele compared with controls (P value is nonsig-
nificant in Dutch, U.K., and Irish cohorts).6 When we in-
vestigated the T1D proxy SNP rs4505848 in our AIDs co-
hort, we did not detect significant associations with either
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Figure 1. The frequency of rs6822844 and rs4505848 alleles in Dutch AIDs cohorts and controls and in a meta-analysis of Dutch,
U.K., and Irish AIDs cohorts. Dutch AIDs cohorts include T1D ( ), CD ( ), and RA ( ). Data for the U.K. andnp 670 np 1,012 np 2,024
Irish cohorts were extracted from the work of van Heel et al.6 n p Number of chromosomes. ORs and the corresponding 95% CIs were
estimated using a random-effect model. Vertical lines represent no effect (i.e., disease risk p 1).
T1D or RA, although there was a similar increase in fre-
quency of the G allele in both groups (fig. 1). Our hap-
lotype analysis showed that a single haplotype shows con-
sistent association with the majority of the decreased risk
for AID. The rs6822844*T allele differentiates this haplo-
type perfectly from the others, indicating that, in our data
set, this allele is the best proxy for the unknown disease
variant. Further investigation of this region, including
comprehensive detection and testing of all variants, is re-
quired to pinpoint the underlying disease variant.
The 4q27-associated block contains four genes:
KIAA1109, Tenr, IL2, and IL2. The extensive LD within
this block means that none of these genes could be ex-
cluded by genetic methods from being the causal one.
The two genes IL2 and IL21 are both plausible functional
candidates as genetic modifiers of autoimmunity. The
importance of the IL2 pathway in T1D is underpinned
by recent findings that have shown that regulatory vari-
ants in the IL2 gene modify the predisposition to organ-
specific AID in NOD mice.7 The IL2 receptor (CD25) is
also a proven T1D-susceptibility locus that has recently
been reported to be associated with RA.15 These consid-
erations highlight the importance of the IL2 pathway in
autoimmunity.
IL21 is involved in both cell-mediated and humoral re-
sponses and has a pleiotropic effect on a variety of im-
mune and nonimmune cells.10 A crucial role of IL21 in
autoimmune pancreatic B-cell destruction was demon-
strated in NOD mice,20 and a contribution from IL21 to
the progression of lupus in mouse models has also been
reported.21,22 IL21 has a crucial role in regulation of an-
tibody production. The role of IL21 in eliminating auto-
reactive B cells through apoptosis suggests that dysregu-
lation of IL21-IL21 receptor signaling might contribute to
the development of antibody-mediated AIDs.10
In conclusion, we have now shown association of T1D
and RA with the KIAA1109/Tenr/IL2/IL21 region. Summa-
rizing our findings with previous data about the associa-
tion of 4q27 with CD and T1D leads us to conclude that
the KIAA1109/Tenr/IL2/IL21 region is a general autoim-
mune risk locus.
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